Budget Amount *help |
¥4,550,000 (Direct Cost: ¥3,500,000、Indirect Cost: ¥1,050,000)
Fiscal Year 2019: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2018: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2017: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
|
Outline of Final Research Achievements |
Mitochondrial dysfunction is a hallmark of Parkinson's disease. In this study, we showed mitochondrial dysfunction caused by loss of CHCHD2. We also revealed comprehensive metabolic disturbances including mitochondrial dysfunction in a cellular model of Parkinson’s disease. Further, we investigated the anti-amyloid effect of ethylammonium salts in vitro.
|